Phase I Study of BMS-690514 in Japanese Patients With Solid Tumors
Phase I Study of BMS-690514 in Japanese Patients With Solid Tumors
The purpose of this clinical study is to identify the maximum tolerated dose (MTD) of BMS-690514 once daily orally in Japanese subjects with advanced or metastatic solid tumors.
Inclusion Criteria:
Chuo-Ku, Tokyo 104-0045, Japan